文献速递心血管CT

CT冠状动脉血管成像指导的无症状患者心血管风险筛查:时机是否已到?

CT coronary angiography-guided cardiovascular risk screening in asymptomatic patients: is it time?
PubMed 文献 · Clin Radiol · 2021-08-14

综述讨论无症状人群心血管风险筛查现状,指出传统多变量风险评分存在固有缺陷,冠脉钙化评分已获指南推荐,而CT冠状动脉血管成像(CTCA)随辐射降低和预后证据积累,是否应转为筛查工具尚待讨论。

要点

  • 传统多变量风险评分基于人群数据,存在固有缺陷,个体化筛查需非侵入影像补充。
  • 冠脉钙化评分在国家和国际指南中有筛查角色,但CTCA是否替代尚在讨论。
  • CTCA技术持续进步,辐射剂量降低,可识别亚临床动脉粥样硬化并获额外预后数据。

核心结论

  • 传统多变量风险评分存在多处固有缺陷,非侵入影像有助于个体化筛查。
  • 冠脉钙化评分已获国家和国际指南推荐用于筛查,CTCA是否应转为筛查工具尚待讨论。
  • CTCA技术持续改进,辐射降低且预后证据扩展,可识别亚临床动脉粥样硬化。

研究设计与样本

  • 综述性文章,报告当前无症状一级预防场景下心脏CT成像指南、CT技术进展及未来机会。
  • 原文未报告系统检索范围、纳入文献数量或证据分级方法。

诊断标准与关键数值

  • 冠脉钙化评分作为筛查工具在国家和国际指南中有角色。
  • CTCA可提供额外预后数据并潜在识别亚临床动脉粥样硬化。
  • 原文未报告CTCA筛查的敏感度、特异度、AUC或具体阈值。

临床应用与阅片要点

  • 无症状一级预防风险评估时,可参考指南对冠脉钙化评分的推荐。
  • CTCA辐射降低和预后证据扩展,讨论其作为筛查工具的潜力。
  • 关注人工智能技术在CTCA识别亚临床动脉粥样硬化中的应用前景。

局限性

  • 为综述性文章,未报告系统检索策略、纳入文献数量及证据分级。
  • CTCA作为筛查工具的证据尚在积累,是否替代现有策略仍待讨论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Cardiovascular disease (CVD) is the leading cause of death in the UK, whilst millions live with various forms of the disease. Coronary artery disease constitutes a significant portion of this morbidity and mortality, and is the leading cause of premature death. Increasing focus is thus being placed on the optimisation of CVD prevention, where risk screening plays a key role. Indeed, the decline in age-adjusted cardiovascular mortality achieved up to now has been largely attributed to primary preventative therapies (e.g., statins) introduced earlier in the disease process. National initiatives exist to improve cardiovascular health at a population level, but in its current form, CVD screening at the individual level is predominantly undertaken using multivariate risk scores based on population-based data. These have multiple innate flaws, highlighted in this review. Non-invasive imaging plays a key role in the screening of other disease processes, helping to personalise the screening process. Although the coronary artery calcium score as a screening tool has a role in national and international guidance, whether a shift to screening with computed tomography coronary angiography (CTCA) is now appropriate is open for discussion. Image acquisition techniques continue to improve with reducing radiation exposure and an ever-expanding evidence-base for additional prognostic data offered by CTCA. This enables the potential identification of sub-clinical atherosclerosis, including with novel artificial intelligence techniques. This review aims to report current guidelines regarding cardiac CT imaging in the asymptomatic primary prevention setting, advances in various CT technologies and future opportunities for progress in this field.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Graby J, Khavandi A, Thompson D, et al. CT coronary angiography-guided cardiovascular risk screening in asymptomatic patients: is it time? Clin Radiol. 2021. PMID: 34404515. doi:10.1016/j.crad.2021.07.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。